Somnolence: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 16: Line 16:
==Hypersomnia of Central Origin==
==Hypersomnia of Central Origin==
Hypersomnia of central origin is a disorder of severe sleepiness arising from CNS dysfunction of sleep–wake states.  It does not include OSA, circadian rhythm disorders.
Hypersomnia of central origin is a disorder of severe sleepiness arising from CNS dysfunction of sleep–wake states.  It does not include OSA, circadian rhythm disorders.
 
* [[Narcolepsy]]
* Idiopathic hypersomnia: If excessive daytime sleepiness exists without narcolepsy or other sleep disorders.
* Recurrent hypersomnia
* Behaviorally induced insufficient sleep syndrome (Sleep Deprivation)
* Hypersomnia due to other conditions: 
**Neurological disorders, including structural, vascular, traumatic, toxic, infectious, and metabolic encephalopathy.
<ref>{{Cite web  | last =  | first =  | title = http://www.dsm5.org/Pages/Default.aspx | url = http://www.dsm5.org/Pages/Default.aspx | publisher =  | date =  | accessdate = }}</ref>
<ref>{{Cite web  | last =  | first =  | title = http://www.dsm5.org/Pages/Default.aspx | url = http://www.dsm5.org/Pages/Default.aspx | publisher =  | date =  | accessdate = }}</ref>


Line 38: Line 43:
* [[Hypothyroidism]]
* [[Hypothyroidism]]
* [[Increased intracranial pressure]]; for example, [[brain tumors]]
* [[Increased intracranial pressure]]; for example, [[brain tumors]]
* Idiopathic hypersomnia
* [[Infectious mononucleosis]] (glandular fever)
* [[Infectious mononucleosis]] (glandular fever)
* [[Insomnia]]
* [[Insomnia]]
Line 54: Line 58:
** [[Hypnotics]] like [[zopiclone]], or the [[benzodiazepine]] such as [[diazepam]] or [[nitrazepam]] and the [[barbiturate]], such as [[amobarbital]] or [[secobarbital]]
** [[Hypnotics]] like [[zopiclone]], or the [[benzodiazepine]] such as [[diazepam]] or [[nitrazepam]] and the [[barbiturate]], such as [[amobarbital]] or [[secobarbital]]
** Other agents impacting the [[central nervous system]] in sufficient or toxic doses
** Other agents impacting the [[central nervous system]] in sufficient or toxic doses
* [[Narcolepsy]]
* [[Starvation]]
* [[Starvation]]
* [[Sleep apnea]]
* [[Sleep apnea]]

Revision as of 01:05, 10 March 2014

For patient information, click here

Somnolence
ICD-10 R40.0
ICD-9 780.09

Template:Search infobox Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

Overview

Somnolence (or "drowsiness") is a state of near-sleep, a strong desire for sleep, or sleeping for unusually long periods. It has two distinct meanings, referring both to the usual state preceding falling asleep, and the chronic condition referring to being in that state independent of a circadian rhythm. The disorder characterized by the latter condition is most commonly associated with users of prescription hypnotics, such as mirtazapine or zolpidem.

It is considered a lesser impairment of consciousness than stupor or coma.

Hypersomnia of Central Origin

Hypersomnia of central origin is a disorder of severe sleepiness arising from CNS dysfunction of sleep–wake states. It does not include OSA, circadian rhythm disorders.

  • Narcolepsy
  • Idiopathic hypersomnia: If excessive daytime sleepiness exists without narcolepsy or other sleep disorders.
  • Recurrent hypersomnia
  • Behaviorally induced insufficient sleep syndrome (Sleep Deprivation)
  • Hypersomnia due to other conditions:
    • Neurological disorders, including structural, vascular, traumatic, toxic, infectious, and metabolic encephalopathy.

[1]

Causes

Hazards

Somnolence can be dangerous when performing tasks that require constant concentration, such as driving a vehicle. When a person is sufficiently fatigued, he or she may experience microsleeps (loss of concentration).

See also

References

  1. "http://www.dsm5.org/Pages/Default.aspx". External link in |title= (help)
  2. Zimmermann C, Pfeiffer H (January 2007). "[Sleep disorders in depression. Suggestions for a therapeutic approach]". Nervenarzt (in German). 78 (1): 21–30. doi:10.1007/s00115-006-2111-1. PMID 16832696.
  3. Watanabe N, Omori IM, Nakagawa A; et al. (2011). "Mirtazapine versus other antidepressive agents for depression". Cochrane Database Syst Rev (12): CD006528. doi:10.1002/14651858.CD006528.pub2. PMID 22161405.
  4. "http://www.dsm5.org/Pages/Default.aspx". External link in |title= (help)

Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:SleepSeries2

Template:Disease-stub